Article
Recent progress in mapping the emerging landscape of the small-cell lung cancer genome.
Experimental & molecular medicine - 12 Dec 2019
Kim Kee-Beom, Dunn Colin T, Park Kwon-Sik
Abstract excerpt
Small-cell lung cancer (SCLC) remains the deadliest of all the lung cancer types. Its high mortality is largely attributed to the invariable development of resistance to standard chemo/radiotherapies, which have remained unchanged for the past 30 years, underscoring the need for new therapeutic approaches. The discovery of molecular targets for chemoprevention and treatment has been hampered by the poor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
